These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 30234233)

  • 1. [A case of Anderson-Fabry disease: a multidisciplinary approach for diagnosis and follow up].
    Zito A; De Pascalis A; Armeni A; Ria P; Barbarini L; Caggiula M; My F; Barbarini S; Trianni G; Napoli M
    G Ital Nefrol; 2018 Sep; 35(5):. PubMed ID: 30234233
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comprehensive clinical evaluation of a large Spanish family with Anderson-Fabry disease, novel GLA mutation and severe cardiac phenotype.
    San Román-Monserrat I; Moreno-Flores V; López-Cuenca D; Rodríguez-González-Herrero E; Guillén-Navarro E; Rodríguez-González-Herrero B; Alegría-Fernández M; Poza-Cisneros G; Piñero-Fernández JA; Sornichero-Martínez J; Gimeno-Blanes JR
    Med Clin (Barc); 2014 Jun; 142(11):497-504. PubMed ID: 24679964
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fabry disease presenting as apical left ventricular hypertrophy in a patient carrying the missense mutation R118C.
    Caetano F; Botelho A; Mota P; Silva J; Leitão Marques A
    Rev Port Cardiol; 2014 Mar; 33(3):183.e1-5. PubMed ID: 24661928
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enzyme replacement therapy in Fabry disease patients undergoing dialysis: effects on quality of life and organ involvement.
    Pisani A; Spinelli L; Sabbatini M; Andreucci MV; Procaccini D; Abbaterusso C; Pasquali S; Savoldi S; Comotti C; Cianciaruso B
    Am J Kidney Dis; 2005 Jul; 46(1):120-7. PubMed ID: 15983965
    [TBL] [Abstract][Full Text] [Related]  

  • 5. De novo mutation in a male patient with Fabry disease: a case report.
    Iemolo F; Pizzo F; Albeggiani G; Zizzo C; Colomba P; Scalia S; Bartolotta C; Duro G
    BMC Res Notes; 2014 Jan; 7():11. PubMed ID: 24398019
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of Fabry Disease in a Tertiary Referral Cohort of Patients with Hypertrophic Cardiomyopathy.
    Maron MS; Xin W; Sims KB; Butler R; Haas TS; Rowin EJ; Desnick RJ; Maron BJ
    Am J Med; 2018 Feb; 131(2):200.e1-200.e8. PubMed ID: 28943383
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiovascular outcomes in Fabry disease are linked to severity of chronic kidney disease.
    Talbot AS; Lewis NT; Nicholls KM
    Heart; 2015 Feb; 101(4):287-93. PubMed ID: 25381325
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fabry disease--a diagnostic and therapeutic problem.
    Strujić BJ; Jeren T
    Ren Fail; 2005; 27(6):783-6. PubMed ID: 16350834
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Diagnosis of Fabry disease: usefulness of the clinical investigation].
    Demontis R
    Rev Med Interne; 2010 Dec; 31 Suppl 2():S229-32. PubMed ID: 21211670
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of Anderson-Fabry Disease.
    Simonetta I; Tuttolomondo A; Daidone M; Miceli S; Pinto A
    Curr Pharm Des; 2020; 26(40):5089-5099. PubMed ID: 32183665
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Cardiological follow-up in patients with Fabry disease].
    Pieruzzi F; Pieroni M; Chimenti C; Frustaci A; Sarais C; Cecchi F;
    G Ital Cardiol (Rome); 2010; 11(7-8):566-72. PubMed ID: 21033333
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiac involvement in Fabry disease - A non-invasive assessment and the role of specific therapies.
    Hongo K
    Mol Genet Metab; 2022; 137(1-2):179-186. PubMed ID: 36088815
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Control of proteinuria with increased doses of agalsidase alfa in a patient with Fabry disease with atypical genotype-phenotype expression.
    Paliouras C; Aperis G; Lamprianou F; Ntetskas G; Roufas K; Alivanis P
    Nefrologia; 2015; 35(6):578-81. PubMed ID: 26384850
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The unusual couple: a clinical case of coexistence between aHUS and Fabry's disease].
    Coppola S; Cuomo V; Riccio CG; d'Apice L; de Simone W; Capasso G
    G Ital Nefrol; 2019 Feb; 36(1):. PubMed ID: 30758152
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Priapism: a severe paediatric complication of Fabry disease].
    Labarthe F; de Bodman C; Maruani A; Szwarc C; Froissart R; Lorette G; Lardy H
    Rev Med Interne; 2010 Dec; 31 Suppl 2():S217-9. PubMed ID: 21211667
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gastroenterological complications of Anderson-Fabry disease.
    Buda P; Książyk J; Tylki-Szymanska A
    Curr Pharm Des; 2013; 19(33):6009-13. PubMed ID: 23448457
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rare presentation of Fabry disease as 'burnt-out' hypertrophic cardiomyopathy.
    Williams S; El-Medany A; Nightingale A; Ismail Y
    BMJ Case Rep; 2021 Sep; 14(9):. PubMed ID: 34479887
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anderson-Fabry disease and the heart.
    O'Mahony C; Elliott P
    Prog Cardiovasc Dis; 2010; 52(4):326-35. PubMed ID: 20109602
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Cardiac manifestations of Anderson-Fabry disease and efficacy of enzyme replacement therapy].
    Hagège A
    Rev Med Interne; 2010 Dec; 31 Suppl 2():S238-42. PubMed ID: 21211672
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-Term Effects of Enzyme Replacement Therapy for Anderson-Fabry Disease.
    Tsujiuchi M; Ebato M; Maezawa H; Mizukami T; Nogi A; Ikeda N; Iso Y; Suzuki H
    Int Heart J; 2019 Jan; 60(1):208-214. PubMed ID: 30464119
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.